Risk-preference differentiates orbitofrontal cortex responses to freely chosen reward outcomes.
To successfully evaluate potential courses of action and choose the most favorable, we must consider the outcomes that may result. Many choices involve risk, our assessment of which may lead us to success or failure in matters financial, legal or health-related. The orbitofrontal cortex (OFC) has been implicated as critical for evaluating choices based on risk. To measure how outcomes of risky decisions are represented in the OFC, we recorded the electrophysiological activity of single neurons while rats made behavioral responses to obtain rewards under conditions of either certainty or risk. Rats exhibited different risk-preferences when given the opportunity to choose. In risk-preferring rats, OFC responses were enhanced following the delivery of large rewards obtained under risk compared with smaller, certain rewards and reward omission. However, in risk-neutral rats, neurons showed similarly enhanced responses to both large rewards obtained under risk and smaller, certain rewards compared with reward omission. Thus, the responses of OFC neurons reflected the subjective evaluation of outcomes in individuals with different risk-preferences. Such enhanced neural responding to risky rewards may serve to bias individuals towards risk-preference in decision-making.
Roitman
Jamie D
JD
Department of Psychology, University of Illinois at Chicago, Chicago, IL, USA. jroitman@uic.edu
Roitman
Mitchell F
MF
D000200:Action Potentials; D000818:Animals; D002755:Choice Behavior / Q000502:physiology*; D003657:Decision Making / Q000502:physiology; D004567:Electrodes, Implanted; D005625:Frontal Lobe / Q000502:physiology*; D008297:Male; D008839:Microelectrodes; D009474:Neurons / Q000502:physiology*; D009483:Neuropsychological Tests; D051381:Rats; D017207:Rats, Sprague-Dawley; D012201:Reward; D012306:Risk; D013997:Time Factors
J Neurosci. 2008 Nov 5;28(45):11703-11
18987206
J Cogn Neurosci. 2009 Aug;21(8):1642-52
18823238
Neuroimage. 2008 Aug 15;42(2):902-10
18582578
Nat Neurosci. 2005 Sep;8(9):1220-7
16116449
Trends Neurosci. 2006 Feb;29(2):116-24
16406092
Cereb Cortex. 2000 Mar;10(3):295-307
10731224
Nat Rev Neurosci. 2005 Sep;6(9):691-702
16136173
Nature. 2008 Sep 11;455(7210):227-31
18690210
Curr Opin Pharmacol. 2005 Feb;5(1):20-5
15661621
J Neurosci. 2005 May 18;25(20):5013-23
15901782
Proc Natl Acad Sci U S A. 2009 Apr 28;106(17):7185-90
19369207
Neuropsychopharmacology. 2009 Feb;34(3):681-97
18668030
J Neurochem. 2008 Sep;106(6):2489-501
18673451
Science. 2004 Apr 9;304(5668):307-10
15073380
Psychopharmacology (Berl). 2002 Oct;163(3-4):362-80
12373437
J Neurosci. 2009 Apr 22;29(16):5251-9
19386921
Neuron. 2005 Feb 17;45(4):587-97
15721244
J Neurosci. 2006 Jan 4;26(1):217-22
16399690
Prog Neurobiol. 2005 Feb;75(2):143-60
15784304
Trends Neurosci. 2007 May;30(5):203-10
17400301
J Neurophysiol. 2009 Jun;101(6):3284-93
19339460
Annu Rev Neurosci. 2007;30:31-56
17417936
Neuron. 2005 Sep 1;47(5):633-6
16129393
Brain Res. 1984 Nov;320(1):65-98
6440660
Neuron. 2006 Aug 17;51(4):509-20
16908415
Neuron. 2007 Apr 5;54(1):51-8
17408577
Neuron. 2008 Oct 9;60(1):19-25
18940585
Neuron. 2001 May;30(2):619-39
11395019
Neuroimage. 2009 Jan 15;44(2):600-9
18804540
Neuroscience. 1991;44(1):1-14
1722886
Brain. 2004 May;127(Pt 5):1108-26
14985269
Science. 2005 Dec 9;310(5754):1680-3
16339445
Ann N Y Acad Sci. 2007 Dec;1121:431-46
17846160
Neuroscience. 2007 Mar 2;145(1):225-31
17204373
Arch Gen Psychiatry. 2006 Nov;63(11):1225-36
17088503
Cereb Cortex. 2009 Oct;19(10):2240-7
19131436